Cloetta (OM:CLA B) just secured nationwide supplier status with Target in the U.S., placing Ahlgrens bilar on shelves in more than 2,000 stores and on Target.com.
The Target deal comes after a mixed period for Cloetta’s shareholders, with the share price at SEK53.65 following a 1-day share price return of 1.13%, a 90-day share price return of 7.86% and a year-to-date share price return of 32.86%. The 1-year total shareholder return of 60.62% points to strong longer term momentum despite some recent weakness over the past week.
Scan how Cloetta compares with other confectionery and consumer staples plays on our curated list of list of solid balance sheet and fundamentals (194 results) before you move on.
Cloetta now trades well above where it started the year after the Target news, which leaves you with a choice: pay up for the momentum, or wait and risk missing further repricing as the valuation case unfolds.
Cloetta’s most followed valuation story pegs fair value at SEK59 per share, which sits above the latest close at SEK53.65 and frames the recent Target push in a bigger context.
The analysts have a consensus price target of SEK59.0 for Cloetta based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be SEK9.6 billion, earnings will come to SEK904.7 million, and it would be trading on a PE ratio of 21.2x, assuming you use a discount rate of 5.3%.
Want to see what kind of revenue glide path, margin rebuild and future earnings multiple this narrative needs to justify that SEK59 figure for Cloetta? The full story spells out a tight set of assumptions around gradual growth, higher profitability and a premium valuation. You will probably want to test these against your own expectations before leaning on this fair value.
Result: Fair Value of SEK59 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Cloetta story can shift quickly if new formats fail to scale or if international expansion absorbs cash without lifting earnings meaningfully.
Find out about the key risks to this Cloetta narrative.
The first story paints Cloetta as roughly 9.1% undervalued at SEK59 per share, yet the market is already paying a richer earnings tag than for many peers. At a P/E of 18.2x versus 16.9x for similar companies and a fair ratio of 16.3x, investors are effectively prepaying for some of that future progress. Does that premium feel comfortable given the moderate growth outlook and already improved margins?
See what the numbers say about this price — find out in our valuation breakdown.
Mixed signals on Cloetta so far. For a clearer view, move quickly, test the numbers yourself, and weigh the 3 key rewards and 1 important warning sign.
If you stop with Cloetta, you risk missing other compelling setups that fit your style. Broaden your watchlist with a few targeted screeners today.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com